go back

Urine Two-Gene Prostate Cancer Risk Test

Washington, DC rates for HCPCS 0339U

Helps judge whether a man is likely to have prostate cancer serious enough to need a biopsy. The activity of two genes, HOXC6 and DLX1, is measured in a urine sample collected straight after a digital rectal examination, and the result is reported as a probability.

Rates data updated July 2026.

Facilitymedian $575 · 10th–90th $575$1,2880%50%90th$575Professionalmedian $575 · 10th–90th $550$5890%50%10th90th$575$1.0$5.0$20.0$100.0$500.0$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$575.44
Median
$575.44
Typical High
$575.44
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562.34
Median
$575.44
Typical High
$588.84
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$549.54
Median
$549.54
Typical High
$724.44
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,230.27
Median
$1,288.25
Typical High
$2,884.03
Cigna
Setting
Professional
Modifier
Global
Typical Low
$891.25
Median
$891.25
Typical High
$977.24
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$870.96
Typical High
$1,548.82
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$316.23
Typical High
$316.23
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$338.84
Typical High
$707.95